Doctor reacts to AI breast cancer tool

What happened: Clairity Breast, a new FDA-approved AI tool, is being offered by its providers, who claim it gives an accurate five-year breast cancer risk assessment. Dr. Céline Gounder shared her thoughts on it. Key numbers: $249 for the assessment; five-year risk window. Why it matters: The content presents the tool's claimed accuracy and price alongside a doctor's reaction, framing the discussion around how the assessment is positioned for patients.

Clairity Breast, a new FDA-approved AI tool, is being offered by its providers, who claim it gives an accurate five-year breast cancer risk assessment. Dr. Céline Gounder shared her thoughts on it.

The content presents the tool's claimed accuracy and price alongside a doctor's reaction, framing the discussion around how the assessment is positioned for patients.